ImmuCell Corp (ICCC)
5.42
+0.13
(+2.46%)
USD |
NASDAQ |
May 10, 16:00
5.42
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Gross Profit Margin (Quarterly): 24.68% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.68% |
| September 30, 2023 | 23.48% |
| June 30, 2023 | 29.55% |
| March 31, 2023 | 8.73% |
| December 31, 2022 | 25.37% |
| September 30, 2022 | 38.49% |
| June 30, 2022 | 44.22% |
| March 31, 2022 | 51.72% |
| December 31, 2021 | 47.04% |
| September 30, 2021 | 46.96% |
| June 30, 2021 | 45.67% |
| March 31, 2021 | 39.01% |
| December 31, 2020 | 43.30% |
| September 30, 2020 | 46.27% |
| June 30, 2020 | 43.27% |
| March 31, 2020 | 45.54% |
| December 31, 2019 | 50.61% |
| September 30, 2019 | 48.86% |
| June 30, 2019 | 46.08% |
| March 31, 2019 | 49.91% |
| December 31, 2018 | 47.54% |
| September 30, 2018 | 44.15% |
| June 30, 2018 | 49.32% |
| March 31, 2018 | 47.19% |
| December 31, 2017 | 38.70% |
| Date | Value |
|---|---|
| September 30, 2017 | 46.68% |
| June 30, 2017 | 52.66% |
| March 31, 2017 | 60.72% |
| December 31, 2016 | 55.05% |
| September 30, 2016 | 61.21% |
| June 30, 2016 | 52.19% |
| March 31, 2016 | 58.85% |
| December 31, 2015 | 61.52% |
| September 30, 2015 | 65.20% |
| June 30, 2015 | 57.67% |
| March 31, 2015 | 59.68% |
| December 31, 2014 | 60.89% |
| September 30, 2014 | 60.89% |
| June 30, 2014 | 57.06% |
| March 31, 2014 | 55.24% |
| December 31, 2013 | 38.97% |
| September 30, 2013 | 49.87% |
| June 30, 2013 | 57.35% |
| March 31, 2013 | 57.05% |
| December 31, 2012 | 52.80% |
| September 30, 2012 | 57.67% |
| June 30, 2012 | 57.06% |
| March 31, 2012 | 58.97% |
| December 31, 2011 | 55.58% |
| September 30, 2011 | 52.42% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
8.73%
Minimum
Mar 2023
51.72%
Maximum
Mar 2022
39.41%
Average
44.22%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.17% |
| Return on Assets | -13.10% |
| Return on Invested Capital | -14.99% |
| Profit Margin (Quarterly) | -22.37% |
| Operating Margin (Quarterly) | -19.69% |
| Return on Net Operating Assets | -13.97% |